High‐sensitive determination of human α‐thrombin by its 29‐mer aptamer in affinity probe capillary electrophoresis

ACE technique provides an effective tool for the separation and identification of disease‐related biomarkers in clinical analysis. In recent years, a couple of synthetic DNA or RNA oligonucleotides, known as aptamers, rival the specificity and affinity for targets to antibodies and are employed as one kind of powerful affinity probe in ACE. In this work, based on high affinity between antithrombin aptamer and thrombin (their dissociation constant is 0.5 nM), a carboxyfluorescein‐labeled 29‐nucleotide (nt) aptamer (F29‐mer) was used and an aptamer‐based affinity probe CE (aptamer‐based APCE) method was successfully established for high‐sensitive detection and quantitative analysis of thrombin. Experimental conditions including incubation temperature and time, buffer composition, and concentration of cations were investigated and optimized. Under the optimized condition, the linear range was from 0 to 400 nM and the LOD was 2 nM (74 ng/mL, S/N = 3), i.e., 40 amol, both in running buffer and in 5% v/v human serum. This LOD is the lowest one than those achieved by the previous APCE methods but based on a 15‐mer aptamer. This approach offers a promising method for the rapid, selective, and sensitive detection of thrombin in practical utility. Further binding experiments using one carboxyfluorescein‐labeled aptamer and the other nonlabeled aptamer or vice versa were carried out to deduce the formation of ternary complex when these two aptamers coexisted in the free solution with thrombin.

[1]  F. Church,et al.  Effect of oligodeoxynucleotide thrombin aptamer on thrombin inhibition by heparin cofactor II and antithrombin , 2000, FEBS letters.

[2]  R. Kennedy,et al.  Aptamers as ligands in affinity probe capillary electrophoresis. , 1998, Analytical chemistry.

[3]  Abdul Malik,et al.  Effect of buffer, electric field, and separation time on detection of aptamer‐ligand complexes for affinity probe capillary electrophoresis , 2003, Electrophoresis.

[4]  P. Bummer,et al.  Foam fractionation of binary mixtures of lysozyme and albumin. , 2000, Journal of pharmaceutical sciences.

[5]  Siqing Shan,et al.  Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Weitz,et al.  Evidence for Allosteric Linkage between Exosites 1 and 2 of Thrombin* , 1997, The Journal of Biological Chemistry.

[7]  L. Kremser,et al.  Fluorescence labeling of human rhinovirus capsid and analysis by capillary electrophoresis. , 2004, Analytical chemistry.

[8]  F. Etzkorn,et al.  A capillary electrophoresis mobility shift assay for protein-DNA binding affinities free in solution. , 1998, Nucleic acids research.

[9]  M F Kubik,et al.  Oligonucleotide inhibitors of human thrombin that bind distinct epitopes. , 1997, Journal of molecular biology.

[10]  G. Collins,et al.  Aptamer-based detection and quantitative analysis of ricin using affinity probe capillary electrophoresis. , 2006, Analytical chemistry.

[11]  Y. Yoo,et al.  Capillary electrophoretic competitive immunoassay with laser-induced fluorescence detection for methionine-enkephalin. , 2006, Journal of chromatography. A.

[12]  Koji Sode,et al.  Novel electrochemical sensor system for protein using the aptamers in sandwich manner. , 2005, Biosensors & bioelectronics.

[13]  W. Tan,et al.  Protein-protein interaction studies based on molecular aptamers by affinity capillary electrophoresis. , 2004, Analytical chemistry.

[14]  Itamar Willner,et al.  Nucleic acid-functionalized Pt nanoparticles: Catalytic labels for the amplified electrochemical detection of biomolecules. , 2006, Analytical chemistry.

[15]  N. Stellwagen,et al.  DNA and buffers: are there any noninteracting, neutral pH buffers? , 2000, Analytical biochemistry.

[16]  E. Vermaas,et al.  Selection of single-stranded DNA molecules that bind and inhibit human thrombin , 1992, Nature.

[17]  J. Richie,et al.  Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Michael Famulok,et al.  Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy. , 2007, Chemical reviews.

[19]  J. Weitz,et al.  Evidence That Both Exosites on Thrombin Participate in Its High Affinity Interaction with Fibrin* , 2003, Journal of Biological Chemistry.

[20]  J. Szostak,et al.  In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.

[21]  R. Shafer,et al.  Engineering the quadruplex fold: nucleoside conformation determines both folding topology and molecularity in guanine quadruplexes. , 2006, Journal of the American Chemical Society.

[22]  S. Olson,et al.  Binding of Exosite Ligands to Human Thrombin , 2002, The Journal of Biological Chemistry.

[23]  M. Mascini,et al.  Analytical applications of aptamers. , 2005, Biosensors & bioelectronics.

[24]  A. Weng,et al.  Stable Suppression of a Novel Oncogene, AHI-1, in Human Cutaneous T-Cell Leukemia Cells Normalizes Its Transforming Activity In Vitro and In Vivo and Aberrant Expression of AHI-1 Is Also Present in Leukemic Sezary Cells from Patients with Sezary Syndrome. , 2005 .